echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Plant Extracts News > The 2015 Pharmacopoeia plans to add 60 kinds of Chinese medicine extracts

    The 2015 Pharmacopoeia plans to add 60 kinds of Chinese medicine extracts

    • Last Update: 2013-07-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    "In the first quarter of this year, the export volume and price of traditional Chinese medicine rose, with the export volume of $710 million, up 20% year on year." Li Yu, deputy director of the science and Technology Department of the State Administration of traditional Chinese medicine, said that traditional Chinese medicine extract is the mainstream of traditional Chinese medicine export, and relevant varieties will be greatly increased in the 2015 Pharmacopoeia

    In recent years, the export of traditional Chinese medicine has continued to grow

    The development of traditional Chinese medicine industry in China has been rapid, and the import and export trade has maintained a rapid growth momentum

    According to the customs data, in the first quarter of 2013, the export of traditional Chinese medicine continued to grow

    The trade volume of four major categories of traditional Chinese medicine products increased by 12% year on year, and the price increased by 8%

    Among them, the export trade volume of traditional Chinese medicine reached $710 million, an increase of 20% year on year

    The pace of "going out" of traditional Chinese medicine is becoming more and more solid

    From the original single mode of acupuncture and moxibustion medical service products driving the export of traditional Chinese medicine products, it is gradually moving forward to the mode of the whole industrial chain of medical treatment, education, scientific research, trade and culture

    This year, 14 departments, including the Ministry of Commerce and the State Administration of traditional Chinese medicine, jointly formulated several opinions on promoting the development of trade in services of traditional Chinese medicine, striving to continuously improve the quality, grade and added value of exports of services of traditional Chinese medicine

    Li Yu, deputy director of the science and Technology Department of the State Administration of traditional Chinese medicine, said during the first Qihuang forum that the promotion of import and export trade of traditional Chinese medicine cannot be separated from the promotion of modernization and internationalization of traditional Chinese medicine

    The pharmaceutical industry is a resource dependent industry

    The traditional way is to rely on nature and take wild resources as raw materials

    Since the modernization of traditional Chinese medicine, the traditional Chinese medicine industry reached 515.6 billion yuan in 2012, with an average annual growth rate of 20%

    According to the resource characteristics of the traditional Chinese medicine industry, the State Administration of traditional Chinese medicine actively strives for the national financial support, continuously increases the efforts in scientific research and industrial promotion, supports the breeding of traditional Chinese medicine seedlings and the construction of production base, effectively promotes the development of traditional Chinese medicine agriculture, gradually improves the industrial technology level, gradually improves the standard system, continuously expands the scale benefit and produces Product quality is guaranteed

    Extracts are expected to become "new favorite" traditional Chinese medicine products, including traditional Chinese medicine, traditional Chinese medicine, traditional Chinese medicine health products, plant extracts, etc

    Plant extract industry is a "sunrise industry", accounting for the largest proportion of exports of traditional Chinese medicine products, nearly half of which

    In 2010, the export value of plant extracts reached 820 million US dollars, and in 2011, the export value exceeded 1 billion US dollars

    In 2012, the growth of foreign trade of plant extracts slowed down, with the export volume of US $1.16 billion

    In the first quarter of 2013, China's import and export of plant extracts amounted to US $410 million, an increase of 12.1% year-on-year, including US $330 million, an increase of 11.2% year-on-year, accounting for 47% of the export of traditional Chinese medicine

    Li Yu introduced that the traditional Chinese medicine extract is the mainstream of the export of traditional Chinese medicine

    At present, the relevant departments are in the process of revising the 2015 edition of Chinese Pharmacopoeia

    Following the 27 new pharmacopoeia in 2010 edition, the 2015 edition of Chinese Pharmacopoeia plans to add 60 new varieties of traditional Chinese Medicine extract

    Plant extract is one of the fastest growing industries in the export industry of traditional Chinese medicine in China

    The joint efforts of the national competent authorities are expected to accelerate the healthy development of the industry

    In late June this year, China Chamber of Commerce for import and export of medical and health products issued the international business standards for the first 10 plant extracts, including blueberry extract, ginkgo price leaf extract, Centella price extract, etc

    As a sub industry that is most likely to realize internationalization in the field of traditional Chinese medicine, the release of standards will promote the quality of products and accelerate the process of internationalization of traditional Chinese medicine

    The international business standards for plant extracts formulated this time are aimed at the export products facing the international market, which are applicable to the export of products to the international markets such as the European Union and the United States

    Under the policy support, the listed companies of plant extracts are expected to benefit from it

    Kangenbei's leading product is ginkgo price extract, which is the first company to develop ginkgo price leaf preparation in China

    Shanghai Nord Biotechnology Industry Co., Ltd., a subsidiary of ANGLI, Jiaotong University, is the largest plant extract enterprise in China

    Its main products include tea polyphenols, Siraitia fruit price extract, artemisinin, etc

    Rhine's leading products include grape seed extract, Rhodiola price extract, Siraitia grosvenorii price extract, etc

    it is one of the enterprises capable of producing the most complete varieties of plant extracts in China, and has mastered the production technology of more than 200 kinds of plant extracts.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.